Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Immunity|September 21, 2018
Tissue Crosstalk in T1D: Is Insulin Special?Braxton L Jamison, Kathryn HaskinsCurrent Opinion in Endocrinology, Diabetes, and Obesity|June 6, 2019
Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetesRocky L Baker, Braxton L Jamison, Kathryn HaskinsJournal of Immunology (Baltimore, Md. : 1950)|May 22, 2019
Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T CellsBraxton L Jamison, Tobias Neef, Andrew Goodspeed, et al.Immunohorizons|September 29, 2021
In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific ImmunotherapyMinh N Pham, Liliane Khoryati, Braxton L Jamison, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cellsBraxton L Jamison, Matthew Lawrance, Chun Jing Wang, et al.Diabetes|July 7, 2018
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD MouseRocky L Baker, Braxton L Jamison, Timothy A Wiles, et al.Diabetes|January 10, 2022
Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD MouseBraxton L Jamison, James E DiLisio, K Scott Beard, et al.Cell Reports|November 3, 2024
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergyBraxton L Jamison, Matthew Lawrance, Chun Jing Wang, et al.Nature Communications|March 24, 2026
Antigen-specific immunotherapy with a CD4+ T cell neoepitope restrains CD8+ T cell differentiation in murine pancreatic islet graftsJames E DiLisio, K Scott Beard, Tobias Neef, et al.Pageof 1